 |
| |
NEW—SUMMARY REPORT
Click Here to download report.*
*This file is in PDF format, which requires the free Adobe Acrobat Reader for viewing.
|
The National Institute on Diabetes and Digestive and Kidney Diseases (NIDDK) and the Food and Drug Administration (FDA) will be facilitating a workshop entitled "Predictors, Pathogenesis, and Prevention of Insulin Resistance and Type 2 Diabetes." The meeting will be held October 4-5, 2006, in the Natcher Conference Center on the NIH campus in Bethesda, MD. The goals of the meeting are to:
- Share the latest information about predictors for type 2 diabetes and discuss obstacles and solutions for widespread use of a predictor system.
- Explore potential common etiology pathways for development of syndromes associated with insulin resistance, obesity, and type 2 diabetes.
- Reexamine the adequacy of the current data to support an indication to treat for prevention of diabetes.
The key questions to be answered by the end of the meeting are:
- What important, unanswered issue can only be answered through a large clinical trial?
- Is there any area that is not being explored that could benefit from targeted funding opportunities?
- What would you consider sufficient evidence to justify a pharmacological treatment to prevent or delay the onset of type 2 diabetes?
|
|